Quote:

---

I know it's all about COVID 19 right now, but surely we have gotten more TNBC (or any other cancer update) data back right now, right?

---

Data is still being collected data. As someone that has participated in clinical medical research the clinicians are most certainly still sending their results to the company.

Cytodyn is a small by all accounts. With the current focus on CV-19 and minimal resources I would imagine that a lot of that data and information is being delayed or prioritized to a lesser degree.

Quote:

---

Are they holding that back thinking it's not the focus right now and the news wouldn't be as impactful?

---

I have ZERO experience in PR or running a biopharm company, but, if it were me, I would focus on CV-19. That will bring a lot of awareness to the company and will save lives.

In the background, continue to collect and organize as much TNBC data as possible. When CV-19 starts to fade then announce the positive results from TNBC that has been quietly collected. Announcing 25 positive results is much more impactful than the 2 to 3 we hear about at a time.

Just keep the positive PR rolling.